Literature DB >> 7337979

Molecular analysis of complement-fixing rheumatoid synovial fluid immune complexes.

D K Male, I M Roitt.   

Abstract

The characteristics of the solid-phase conglutinin method for the isolation of C3-containing complexes from the synovial effusions of rheumatoid arthritis patients were assessed. All major proteins in such complexes were identified and shown to be either immunoglobulin or complement components. The high proportion of IgM and the association between complexed IgM and latex agglutination titre suggest that IgM rheumatoid factor, probably binding to self-associated IgG antiglobulins, is of major importance in the formation of complement-fixing complexes. A minority of samples contained unidentified trace components and these differed from one fluid to another. The levels of complexed immunoglobulins were closely correlated to the titres of synovial fluid antiglobulins. The data accords with the view that autosensitization to IgG plays the primary role in the development of immunopathological features of rheumatoid arthritis.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7337979      PMCID: PMC1536289     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  10 in total

1.  Antibodies to DNA in patients with rheumatoid arthritis and juvenile rheumatoid arthritis.

Authors:  C Bell; N Talal; P H Schur
Journal:  Arthritis Rheum       Date:  1975 Nov-Dec

2.  Analysis of the components of immune complexes.

Authors:  D Male; I M Roitt
Journal:  Mol Immunol       Date:  1979-03       Impact factor: 4.407

3.  Interaction between the third complement protein and cell surface macromolecules.

Authors:  S K Law; R P Levine
Journal:  Proc Natl Acad Sci U S A       Date:  1977-07       Impact factor: 11.205

4.  Gamma globulin complexes in synovial fluids of patients with rheumatoid arthritis. Partial characterization and relationship to lowered complement levels.

Authors:  R J Winchester; V Agnello; H G Kunkel
Journal:  Clin Exp Immunol       Date:  1970-05       Impact factor: 4.330

5.  The complement system in rheumatoid synovitis. I. An analysis of complement component activities in rheumatoid synovial fluids.

Authors:  S Ruddy; K F Austen
Journal:  Arthritis Rheum       Date:  1970 Nov-Dec

6.  Binding of circulating immune complexes to human peripheral blood lymphocytes: effect of complement.

Authors:  G M Kammer; P H Schur
Journal:  Clin Immunol Immunopathol       Date:  1978-06

7.  Purification of soluble immune complexes from serum using polymethylmetacrylate beads coated with conglutinin or C1q. Application to the analysis of the components of in vitro formed immune complexes and of immune complexes occurring in vivo during leishmaniasis.

Authors:  P Casali; P H Lambert
Journal:  Clin Exp Immunol       Date:  1979-08       Impact factor: 4.330

8.  Analysis of immune complexes in synovial effusions of patients with rheumatoid arthritis.

Authors:  D Male; I M Roitt; F C Hay
Journal:  Clin Exp Immunol       Date:  1980-02       Impact factor: 4.330

9.  Phagocytosis of immune complexes by macrophages. Different roles of the macrophage receptor sites for complement (C3) and for immunoglobulin (IgG).

Authors:  B Mantovani; M Rabinovitch; V Nussenzweig
Journal:  J Exp Med       Date:  1972-04-01       Impact factor: 14.307

10.  Human C4-binding protein. II. Role in proteolysis of C4b by C3b-inactivator.

Authors:  T Fujita; I Gigli; V Nussenzweig
Journal:  J Exp Med       Date:  1978-10-01       Impact factor: 14.307

  10 in total
  11 in total

1.  Isolation and analysis of nephritic-producing immune complexes in Plasmodium berghei-infected mice.

Authors:  E J Toran; C M Lee
Journal:  J Natl Med Assoc       Date:  1995-09       Impact factor: 1.798

Review 2.  Antibody-dependent and -independent mechanisms of inflammatory arthritis.

Authors:  Margaret H Chang; Peter A Nigrovic
Journal:  JCI Insight       Date:  2019-03-07

3.  Synovial hyaluronate in rheumatoid arthritis binds C1q and is covalently bound to antibodies: a model for chronicity.

Authors:  P Prehm
Journal:  Ann Rheum Dis       Date:  1995-05       Impact factor: 19.103

4.  Antibodies to EB virus- and cytomegalovirus-induced antigens in early rheumatoid disease.

Authors:  D Male; A Young; C Pilkington; S Sutherland; I M Roitt
Journal:  Clin Exp Immunol       Date:  1982-11       Impact factor: 4.330

Review 5.  Rheumatoid factors in immune complexes of patients with rheumatoid arthritis.

Authors:  M Mannik; F A Nardella; E H Sasso
Journal:  Springer Semin Immunopathol       Date:  1988

6.  Complement activating properties of complexes containing rheumatoid factor in synovial fluids and sera from patients with rheumatoid arthritis.

Authors:  C J Elson; S D Carter; B J Cottrell; D G Scott; P A Bacon; T B Wallington
Journal:  Clin Exp Immunol       Date:  1985-02       Impact factor: 4.330

7.  Possible role of free radical altered IgG in the etiopathogenesis of rheumatoid arthritis.

Authors:  A J Swaak; H A Kleinveld; J F Kloster; C E Hack
Journal:  Rheumatol Int       Date:  1989       Impact factor: 2.631

8.  Isolation and analysis of complement activating aggregates from synovial fluid of patients with rheumatoid arthritis using monoclonal anti-C3d antibodies.

Authors:  A E Bedwell; C J Elson; S D Carter; P A Dieppe; C W Hutton; R Czudek
Journal:  Ann Rheum Dis       Date:  1987-01       Impact factor: 19.103

9.  Anti-C1q affinity isolated circulating immune complexes correlate with extra-articular rheumatoid disease.

Authors:  R D Melsom; A C Horsfall; L Schrieber; P Charles; R N Maini
Journal:  Rheumatol Int       Date:  1986       Impact factor: 2.631

10.  Demonstration of an unidentified 48 kD polypeptide in circulating immune complexes in rheumatoid arthritis.

Authors:  R D Melsom; P R Smith; R N Maini
Journal:  Ann Rheum Dis       Date:  1987-02       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.